Hepatitis C Testing Market

The hepatitis c testing market was valued at $1.3 billion in 2021, and is estimated to reach $2.3 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031.

WILMINGTON, DELAWARE , UNITED STATES, March 22, 2024 /EINPresswire.com/ -- A new business intelligence report released by Allied Market Research, the global Hepatitis C Testing Market size was estimated at $1.3 billion in 2021 and is expected to hit $2.3 billion by 2031, registering a CAGR of 5.3% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝑹𝒆𝒒𝒖𝒆𝒔𝒕 𝑺𝒂𝒎𝒑𝒍𝒆 𝑪𝒐𝒑𝒚 𝒐𝒇 𝑹𝒆𝒑𝒐𝒓𝒕 https://www.alliedmarketresearch.com/request-sample/A17601

The global hepatitis C testing market is thoroughly examined across various parameters including Technique, Test, End-user, and Region. The report provides a comprehensive analysis of segments and their sub-segments through both tabular and graphical representations. Investors and market players can leverage this breakdown to formulate strategies based on the most lucrative revenue-generating segments and those with the highest growth potential, as outlined in the report.

In terms of technique, the immunoassay segment accounted for over two-fifths of the total market revenue in 2021 and is projected to maintain dominance through 2031. Simultaneously, the PCR segment is anticipated to exhibit the fastest Compound Annual Growth Rate (CAGR) of 6.2% throughout the forecast period.

Regarding the test type, the antibody test segment captured nearly three-fifths of the total market revenue in 2021 and is anticipated to continue dominating through 2031. Conversely, the viral load test segment is expected to experience the fastest CAGR of 6.2% during the forecast period.

𝑷𝒖𝒓𝒄𝒉𝒂𝒔𝒆 𝑰𝒏𝒒𝒖𝒊𝒓𝒚:
https://www.alliedmarketresearch.com/purchase-enquiry/18051

In terms of end-users, the hospital and diagnostic laboratory segment contributed to approximately three-fifths of the global hepatitis C testing market revenue in 2021 and is forecasted to maintain its dominance through 2031. Conversely, the blood banks segment is projected to exhibit the fastest Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.

Regarding regional analysis, the North American market accounted for nearly two-fifths of the total market revenue in 2021 and is expected to continue holding the largest share by 2031. On the other hand, the Asia-Pacific region is poised to witness the fastest CAGR of 7.0% during the forecast period. The report also covers insights from other regions including LAMEA and Europe.

𝑲𝒆𝒚 𝑴𝒂𝒓𝒌𝒆𝒕 𝑷𝒍𝒂𝒚𝒆𝒓𝒔
BIO-RAD Laboratories Inc.
Cosara Diagnostics Pvt Ltd
Meril Life Sciences Pvt. Ltd.
Molbio Diagnostics Pvt. Ltd.
PerkinElmer
Qiagen N.V.
Abbott Laboratories
Thermo Fisher Scientific Inc.
Trivitron Healthcare
Illumina Inc.

𝑻𝒓𝒆𝒏𝒅𝒊𝒏𝒈 𝑹𝒆𝒑𝒐𝒓𝒕𝒔 𝒊𝒏 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆 𝑰𝒏𝒅𝒖𝒔𝒕𝒓𝒚 (𝑩𝒐𝒐𝒌 𝑵𝒐𝒘 𝒘𝒊𝒕𝒉 10% 𝑫𝒊𝒔𝒄𝒐𝒖𝒏𝒕):
𝐇𝐲𝐬𝐭𝐞𝐫𝐞𝐜𝐭𝐨𝐦𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/hysterectomy-devices-market-A13324
𝐎𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐢𝐜 𝐏𝐞𝐫𝐢𝐦𝐞𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/ophthalmic-perimeter-market-A13063

David Correa
Allied Market Research
+1 5038946022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.